Visalytics
Visalytics
approved EB-2 (NIW)

PhD Candidate

Biomedical Engineering · Ghana · 2025-04-11

Processing Time
485 days
Decision Date
2025-04-11
Location
New York
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to continue developing innovative pharmacological solutions using engineered peptide-functionalized nanoparticles to enhance tendon regeneration and bone health. Her work focuses on creating advanced drug delivery systems and biomedical devices to address drug resistance in cancer and treat various immune disorders. The research aims to provide cutting-edge tools for tackling chronic health burdens and improving clinical outcomes in the U.S.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The research addresses critical health challenges such as cancer and musculoskeletal disease, aligning with U.S. priorities in biotechnology.

2 Well-positioned to Advance the Endeavor Met

The petitioner's publication record, patent application, and history of NIH/NSF funding demonstrate her capability to lead this research.

3 On Balance, Beneficial to Waive Job Offer Met

The urgent need for innovative therapies and the petitioner's unique expertise make it beneficial for the U.S. to waive the labor certification.

Why This Petition Was Approved

The petition was approved based on the petitioner's record of 6 peer-reviewed articles, 1 patent application, and 30 citations, demonstrating a recognized scientific impact. Evidence of research funding from the National Institutes of Health (NIH) and National Science Foundation (NSF) further established her as well-positioned to advance the endeavor. The case was supported by 4 expert recommendation letters and satisfied all three Dhanasar prongs.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Patents
Reference Letters Independent
Grants
Government Alignment

Similar Cases

Others

Biotechnology · Bangladesh

WeGreened EB-2 (NIW) approved
Pennsylvania 289 days 2025-02-28
The petitioner proposes to design novel biomaterials and wearable devices to advance personalized healthcare through continuous monitoring and early detection of chronic conditions. His work involves developing nanostructured materials for targeted drug delivery and tissue engineering, as well as creating flexible devices capable of capturing physiological signals for diagnosis.
View Case

Scientist

Pharmaceuticals · India

WeGreened EB-2 (NIW) approved
North Carolina 132 days 2024-05-17
The petitioner proposes to continue her research in pharmaceutical sciences, specifically focusing on advancing drug repurposing and the development of nanoparticle-based delivery systems. Her work aims to create smarter, more efficient ways to deliver medications for critical diseases such as cancer and COVID-19. This research is intended to provide faster, cost-effective pathways for translating laboratory discoveries into viable clinical treatments.
View Case

Research Scientist

Materials Science · Pakistan

WeGreened EB-2 (NIW) approved
293 days 2025-03-12
The petitioner proposes to identify ideal materials for biomedical applications and develop innovative cancer drugs. The work focuses on enhancing the quality and accessibility of medical treatments through advancements in artificial heart valves, dental implants, and joint replacements. The research aims to improve patient outcomes and enhance the safety and stability of medical implants.
View Case

Postdoctoral Researcher

Nanotechnology · Jordan

WeGreened EB-2 (NIW) approved
Maryland 90 days 2023-05-13
The petitioner proposes to improve the delivery of mRNA therapeutics to increase the effectiveness of gene therapies for incurable conditions. His work focuses on formulating and characterizing novel nanoparticles and developing advanced animal models to test therapeutics for brain diseases like Alzheimer's and anti-cancer drug delivery.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Biotechnology cases More cases from Ghana

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-04-11.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 485 days
Criteria Met 3 / 3
Evidence Types 6

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in Ghana All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist